LFCR
Lifecore BiomedicalFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
Current thesis
Composite grade F from latest DB weights. Momentum 5.6 / Value 41.1
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
6
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $8.50
Why
Momentum6 · Δ7d -3.8
Value41 · Δ7d +0.0
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
6
52% active weight
Current posture
7d trendFlat
Δ7d
-3.8
Δ21d
-8.3
Value
41
48% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.2
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 5.6 / Value 41.1
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$204.43M
Beta
0.59
Shares Out
37.47M
P/E (TTM) · Derived
-1.6
P/S (TTM)
2.22
P/FCF (TTM) · Derived
-13.95
Rev YoY
-3.8%
EPS YoY
+76.2%
Gross Margin
+31.3%
Op Margin
-13.4%
Net Debt
$122.17M
Current Ratio
2.80
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology